Rank | Gene Set | Z-score |
---|---|---|
1 | protein maturation by protein folding (GO:0022417) | 5.57558069 |
2 | viral transcription (GO:0019083) | 5.50858992 |
3 | translational termination (GO:0006415) | 5.27451240 |
4 | translational elongation (GO:0006414) | 4.94956866 |
5 | ribosomal small subunit assembly (GO:0000028) | 4.85776126 |
6 | establishment of viral latency (GO:0019043) | 4.65171005 |
7 | establishment of integrated proviral latency (GO:0075713) | 4.58806742 |
8 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.57988149 |
9 | protein targeting to ER (GO:0045047) | 4.45483995 |
10 | cotranslational protein targeting to membrane (GO:0006613) | 4.43413802 |
11 | ribosomal small subunit biogenesis (GO:0042274) | 4.39381207 |
12 | DNA deamination (GO:0045006) | 4.30362541 |
13 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.20326972 |
14 | protein localization to endoplasmic reticulum (GO:0070972) | 4.20044680 |
15 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.19450749 |
16 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.18847489 |
17 | translational initiation (GO:0006413) | 4.17923433 |
18 | viral life cycle (GO:0019058) | 4.10000636 |
19 | cellular protein complex disassembly (GO:0043624) | 4.09812498 |
20 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.05468450 |
21 | GDP-mannose metabolic process (GO:0019673) | 3.93324834 |
22 | regulation of mitochondrial translation (GO:0070129) | 3.87418020 |
23 | ribosomal large subunit biogenesis (GO:0042273) | 3.86605256 |
24 | maturation of SSU-rRNA (GO:0030490) | 3.84243543 |
25 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.77708087 |
26 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.75606660 |
27 | nuclear envelope reassembly (GO:0031468) | 3.74177579 |
28 | mitotic nuclear envelope reassembly (GO:0007084) | 3.74177579 |
29 | glycine metabolic process (GO:0006544) | 3.73895856 |
30 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.73142940 |
31 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.69113077 |
32 | Golgi transport vesicle coating (GO:0048200) | 3.68863254 |
33 | COPI coating of Golgi vesicle (GO:0048205) | 3.68863254 |
34 | protein complex disassembly (GO:0043241) | 3.68264607 |
35 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.62484580 |
36 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.58309881 |
37 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.56457989 |
38 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.55727263 |
39 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.51858303 |
40 | macromolecular complex disassembly (GO:0032984) | 3.47058042 |
41 | DNA strand elongation (GO:0022616) | 3.46300918 |
42 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.45679312 |
43 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.45679312 |
44 | translation (GO:0006412) | 3.45254490 |
45 | formation of translation preinitiation complex (GO:0001731) | 3.44478301 |
46 | lysine metabolic process (GO:0006553) | 3.42806211 |
47 | lysine catabolic process (GO:0006554) | 3.42806211 |
48 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.40839440 |
49 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.40839440 |
50 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.40839440 |
51 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.40076897 |
52 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.40076897 |
53 | metallo-sulfur cluster assembly (GO:0031163) | 3.38672285 |
54 | iron-sulfur cluster assembly (GO:0016226) | 3.38672285 |
55 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.37621553 |
56 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.35571952 |
57 | proteasome assembly (GO:0043248) | 3.35435452 |
58 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.32769472 |
59 | serine family amino acid biosynthetic process (GO:0009070) | 3.28445417 |
60 | protein targeting to mitochondrion (GO:0006626) | 3.25321121 |
61 | positive regulation of ligase activity (GO:0051351) | 3.24760469 |
62 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.23857802 |
63 | L-phenylalanine metabolic process (GO:0006558) | 3.23857802 |
64 | pentose-phosphate shunt (GO:0006098) | 3.18654170 |
65 | heme biosynthetic process (GO:0006783) | 3.18612199 |
66 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.17646982 |
67 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.17540009 |
68 | nucleoside salvage (GO:0043174) | 3.15504339 |
69 | oxidative phosphorylation (GO:0006119) | 3.15346874 |
70 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.13373117 |
71 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.12334184 |
72 | oxaloacetate metabolic process (GO:0006107) | 3.10610638 |
73 | histone arginine methylation (GO:0034969) | 3.10010779 |
74 | aldehyde catabolic process (GO:0046185) | 3.09358261 |
75 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.09343522 |
76 | folic acid metabolic process (GO:0046655) | 3.05292171 |
77 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.04516840 |
78 | tetrahydrofolate metabolic process (GO:0046653) | 3.03934638 |
79 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.03653768 |
80 | regulation of ligase activity (GO:0051340) | 3.02577906 |
81 | tricarboxylic acid cycle (GO:0006099) | 3.00533677 |
82 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.99160263 |
83 | establishment of protein localization to mitochondrion (GO:0072655) | 2.98702710 |
84 | protein targeting to membrane (GO:0006612) | 2.96821799 |
85 | serine family amino acid metabolic process (GO:0009069) | 2.95979729 |
86 | UV protection (GO:0009650) | 2.95252468 |
87 | DNA replication initiation (GO:0006270) | 2.95232107 |
88 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.94831996 |
89 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.94831996 |
90 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.93784588 |
91 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.92551914 |
92 | regulation of protein heterodimerization activity (GO:0043497) | 2.92231681 |
93 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.91601452 |
94 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.88854845 |
95 | heme metabolic process (GO:0042168) | 2.88465034 |
96 | spliceosomal snRNP assembly (GO:0000387) | 2.88080786 |
97 | maternal placenta development (GO:0001893) | 2.88023942 |
98 | proline biosynthetic process (GO:0006561) | 2.87711804 |
99 | glyoxylate metabolic process (GO:0046487) | 2.86817386 |
100 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.86169538 |
101 | nucleobase biosynthetic process (GO:0046112) | 2.85314145 |
102 | deoxyribose phosphate catabolic process (GO:0046386) | 2.84845499 |
103 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.84790218 |
104 | ribosome assembly (GO:0042255) | 2.84687468 |
105 | chaperone-mediated protein transport (GO:0072321) | 2.83981654 |
106 | telomere maintenance via recombination (GO:0000722) | 2.83799710 |
107 | deoxyribonucleotide catabolic process (GO:0009264) | 2.83524115 |
108 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.82670737 |
109 | pentose metabolic process (GO:0019321) | 2.82304904 |
110 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.81778990 |
111 | positive regulation of cell cycle arrest (GO:0071158) | 2.80082595 |
112 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.79942359 |
113 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.78852835 |
114 | protein localization to mitochondrion (GO:0070585) | 2.77754263 |
115 | base-excision repair (GO:0006284) | 2.76326315 |
116 | deoxyribose phosphate metabolic process (GO:0019692) | 2.75919999 |
117 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.75259676 |
118 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.74882776 |
119 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.74511154 |
120 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.73872679 |
121 | glucose catabolic process (GO:0006007) | 2.73591298 |
122 | regulation of translational termination (GO:0006449) | 2.73172577 |
123 | de novo posttranslational protein folding (GO:0051084) | 2.72822491 |
124 | nucleotide salvage (GO:0043173) | 2.72201317 |
125 | mRNA catabolic process (GO:0006402) | 2.71912986 |
126 | de novo protein folding (GO:0006458) | 2.71579634 |
127 | ncRNA 3-end processing (GO:0043628) | 2.70721137 |
128 | regulation of mitochondrial membrane potential (GO:0051881) | 2.70302108 |
129 | negative regulation of RNA splicing (GO:0033119) | 2.70231603 |
130 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.70063707 |
131 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.69356339 |
132 | peptidyl-arginine N-methylation (GO:0035246) | 2.69187304 |
133 | peptidyl-arginine methylation (GO:0018216) | 2.69187304 |
134 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.68119865 |
135 | UMP biosynthetic process (GO:0006222) | 2.68119865 |
136 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.68119865 |
137 | UMP metabolic process (GO:0046049) | 2.68119865 |
138 | base-excision repair, AP site formation (GO:0006285) | 2.68103983 |
139 | L-serine metabolic process (GO:0006563) | 2.67825895 |
140 | DNA unwinding involved in DNA replication (GO:0006268) | 2.67715825 |
141 | regulation of cellular amine metabolic process (GO:0033238) | 2.67039384 |
142 | mitotic recombination (GO:0006312) | 2.66800142 |
143 | NADPH regeneration (GO:0006740) | 2.66378395 |
144 | IMP biosynthetic process (GO:0006188) | 2.65449892 |
145 | cullin deneddylation (GO:0010388) | 2.65222951 |
146 | RNA catabolic process (GO:0006401) | 2.65070741 |
147 | NADH metabolic process (GO:0006734) | 2.63274877 |
148 | pyrimidine nucleoside salvage (GO:0043097) | 2.63247222 |
149 | pyrimidine-containing compound salvage (GO:0008655) | 2.63247222 |
150 | protein deneddylation (GO:0000338) | 2.61890303 |
151 | sulfur amino acid catabolic process (GO:0000098) | 2.60083255 |
152 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.59534001 |
153 | telomere maintenance via telomere lengthening (GO:0010833) | 2.59416534 |
154 | ATP synthesis coupled proton transport (GO:0015986) | 2.59053494 |
155 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.59053494 |
156 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.57754102 |
157 | folic acid-containing compound metabolic process (GO:0006760) | 2.57361694 |
158 | valine metabolic process (GO:0006573) | 2.57206051 |
159 | cellular component biogenesis (GO:0044085) | 2.55904834 |
160 | rRNA processing (GO:0006364) | 2.55771370 |
161 | cysteine metabolic process (GO:0006534) | 2.54925514 |
162 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.54805586 |
163 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.54526384 |
164 | pyrimidine nucleoside biosynthetic process (GO:0046134) | 2.53465169 |
165 | negative regulation of ligase activity (GO:0051352) | 2.53339548 |
166 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.53339548 |
167 | ethanol oxidation (GO:0006069) | 2.52874930 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.38542461 |
2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.29863328 |
3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.56103066 |
4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.82893550 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.67462144 |
6 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.60671496 |
7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.49972911 |
8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.45284937 |
9 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.36602598 |
10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.35101980 |
11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.33609714 |
12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.32230765 |
13 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.25314593 |
14 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.19885535 |
15 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.19399622 |
16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.15652947 |
17 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.13860959 |
18 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.13261658 |
19 | MYC_22102868_ChIP-Seq_BL_Human | 2.05377363 |
20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.02509207 |
21 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.91497955 |
22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87449667 |
23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.86170278 |
24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.85026183 |
25 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.84855835 |
26 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.82090960 |
27 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.81358702 |
28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.80171991 |
29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79205967 |
30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.78733462 |
31 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.75134775 |
32 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73095827 |
33 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.68901171 |
34 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.65201189 |
35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.62392140 |
36 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.62370901 |
37 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.61142324 |
38 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.56872803 |
39 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56689635 |
40 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.56489262 |
41 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.54239706 |
42 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.53971962 |
43 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.47938973 |
44 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.46932489 |
45 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.46501830 |
46 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.45240713 |
47 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.45106446 |
48 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.43479851 |
49 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.35438911 |
50 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.34803723 |
51 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.32180615 |
52 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.31401091 |
53 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.29341036 |
54 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.28060205 |
55 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.27663317 |
56 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24998098 |
57 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.24576070 |
58 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.24116871 |
59 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.23475950 |
60 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23105190 |
61 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.22394097 |
62 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22348869 |
63 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.21930913 |
64 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.21543567 |
65 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.20780451 |
66 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.19622854 |
67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.18783660 |
68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.17859938 |
69 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.17175592 |
70 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.16850323 |
71 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.16258523 |
72 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15513020 |
73 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15383077 |
74 | P68_20966046_ChIP-Seq_HELA_Human | 1.15334158 |
75 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.14956590 |
76 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.13144757 |
77 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.12444739 |
78 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.12369749 |
79 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.11792013 |
80 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.11606127 |
81 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11411198 |
82 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.10996829 |
83 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10583440 |
84 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.09644006 |
85 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.09213821 |
86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09113732 |
87 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.08597869 |
88 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08273823 |
89 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.08159671 |
90 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07279699 |
91 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.06989348 |
92 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.06759020 |
93 | MAF_26560356_Chip-Seq_TH2_Human | 1.06409951 |
94 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.05995241 |
95 | MAF_26560356_Chip-Seq_TH1_Human | 1.05959986 |
96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.05615281 |
97 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05361398 |
98 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.04677559 |
99 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.04591804 |
100 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.04390465 |
101 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.03716506 |
102 | UTX_26944678_Chip-Seq_JUKART_Human | 1.03370249 |
103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02814365 |
104 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.02479620 |
105 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.02175366 |
106 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01018164 |
107 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.99922962 |
108 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99715082 |
109 | ATF3_27146783_Chip-Seq_COLON_Human | 0.99536305 |
110 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.99037656 |
111 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.98882465 |
112 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98175477 |
113 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97525277 |
114 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.97174702 |
115 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.97052799 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 4.49834505 |
2 | MP0002139_abnormal_hepatobiliary_system | 4.16979659 |
3 | MP0005451_abnormal_body_composition | 3.53840917 |
4 | MP0005058_abnormal_lysosome_morphology | 3.48515756 |
5 | MP0003693_abnormal_embryo_hatching | 3.15616700 |
6 | MP0008260_abnormal_autophagy | 3.15540806 |
7 | MP0009379_abnormal_foot_pigmentation | 2.94093312 |
8 | MP0003806_abnormal_nucleotide_metabolis | 2.78151885 |
9 | MP0009840_abnormal_foam_cell | 2.72919339 |
10 | MP0005085_abnormal_gallbladder_physiolo | 2.63190613 |
11 | MP0005365_abnormal_bile_salt | 2.60259119 |
12 | MP0005083_abnormal_biliary_tract | 2.52382520 |
13 | MP0004957_abnormal_blastocyst_morpholog | 2.44196438 |
14 | MP0006036_abnormal_mitochondrial_physio | 2.37889846 |
15 | MP0003705_abnormal_hypodermis_morpholog | 2.28078467 |
16 | MP0008875_abnormal_xenobiotic_pharmacok | 2.08757169 |
17 | MP0003186_abnormal_redox_activity | 2.06825428 |
18 | MP0005332_abnormal_amino_acid | 2.01362902 |
19 | MP0000751_myopathy | 1.94356647 |
20 | MP0003656_abnormal_erythrocyte_physiolo | 1.91345948 |
21 | MP0005319_abnormal_enzyme/_coenzyme | 1.88647599 |
22 | MP0003111_abnormal_nucleus_morphology | 1.87545078 |
23 | MP0004233_abnormal_muscle_weight | 1.86332715 |
24 | MP0009333_abnormal_splenocyte_physiolog | 1.83626860 |
25 | MP0003436_decreased_susceptibility_to | 1.71703102 |
26 | MP0003077_abnormal_cell_cycle | 1.69052595 |
27 | MP0010094_abnormal_chromosome_stability | 1.60928320 |
28 | MP0009278_abnormal_bone_marrow | 1.57268882 |
29 | MP0003191_abnormal_cellular_cholesterol | 1.57061414 |
30 | MP0000685_abnormal_immune_system | 1.55277441 |
31 | MP0009643_abnormal_urine_homeostasis | 1.50509513 |
32 | MP0008932_abnormal_embryonic_tissue | 1.50354319 |
33 | MP0003303_peritoneal_inflammation | 1.48002805 |
34 | MP0000747_muscle_weakness | 1.47717885 |
35 | MP0005165_increased_susceptibility_to | 1.47628520 |
36 | MP0003646_muscle_fatigue | 1.45319598 |
37 | MP0003075_altered_response_to | 1.44850027 |
38 | MP0005501_abnormal_skin_physiology | 1.44357201 |
39 | MP0005636_abnormal_mineral_homeostasis | 1.43507493 |
40 | MP0010329_abnormal_lipoprotein_level | 1.43346256 |
41 | MP0006035_abnormal_mitochondrial_morpho | 1.39647467 |
42 | MP0000609_abnormal_liver_physiology | 1.37384532 |
43 | MP0000490_abnormal_crypts_of | 1.37192651 |
44 | MP0003300_gastrointestinal_ulcer | 1.34986984 |
45 | MP0000358_abnormal_cell_content/ | 1.34539853 |
46 | MP0000343_altered_response_to | 1.31975258 |
47 | MP0000598_abnormal_liver_morphology | 1.29891529 |
48 | MP0000858_altered_metastatic_potential | 1.29701394 |
49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.27867553 |
50 | MP0001661_extended_life_span | 1.26474280 |
51 | MP0003329_amyloid_beta_deposits | 1.25240925 |
52 | MP0008469_abnormal_protein_level | 1.24819484 |
53 | MP0008007_abnormal_cellular_replicative | 1.19512113 |
54 | MP0002396_abnormal_hematopoietic_system | 1.19064333 |
55 | MP0001730_embryonic_growth_arrest | 1.18207589 |
56 | MP0009697_abnormal_copulation | 1.16873405 |
57 | MP0003252_abnormal_bile_duct | 1.16150187 |
58 | MP0000759_abnormal_skeletal_muscle | 1.15682948 |
59 | MP0000689_abnormal_spleen_morphology | 1.13269371 |
60 | MP0001545_abnormal_hematopoietic_system | 1.11749269 |
61 | MP0005397_hematopoietic_system_phenotyp | 1.11749269 |
62 | MP0005330_cardiomyopathy | 1.11458256 |
63 | MP0002019_abnormal_tumor_incidence | 1.10674410 |
64 | MP0002722_abnormal_immune_system | 1.10380566 |
65 | MP0001756_abnormal_urination | 1.09975559 |
66 | MP0000750_abnormal_muscle_regeneration | 1.09680388 |
67 | MP0003221_abnormal_cardiomyocyte_apopto | 1.07805519 |
68 | MP0003763_abnormal_thymus_physiology | 1.06874545 |
69 | MP0002398_abnormal_bone_marrow | 1.06494124 |
70 | MP0000313_abnormal_cell_death | 1.05605580 |
71 | MP0000749_muscle_degeneration | 1.04968873 |
72 | MP0004185_abnormal_adipocyte_glucose | 1.03338350 |
73 | MP0005384_cellular_phenotype | 1.03207738 |
74 | MP0002138_abnormal_hepatobiliary_system | 1.01733467 |
75 | MP0002080_prenatal_lethality | 0.99993863 |
76 | MP0005023_abnormal_wound_healing | 0.98619710 |
77 | MP0001663_abnormal_digestive_system | 0.98166805 |
78 | MP0001764_abnormal_homeostasis | 0.97984320 |
79 | MP0003195_calcinosis | 0.96531039 |
80 | MP0009785_altered_susceptibility_to | 0.94938789 |
81 | MP0002269_muscular_atrophy | 0.94899684 |
82 | MP0001853_heart_inflammation | 0.94200940 |
83 | MP0002148_abnormal_hypersensitivity_rea | 0.93988680 |
84 | MP0001727_abnormal_embryo_implantation | 0.93940097 |
85 | MP0002429_abnormal_blood_cell | 0.93817662 |
86 | MP0003718_maternal_effect | 0.93088501 |
87 | MP0000350_abnormal_cell_proliferation | 0.92434586 |
88 | MP0005621_abnormal_cell_physiology | 0.91927481 |
89 | MP0003123_paternal_imprinting | 0.91919698 |
90 | MP0000604_amyloidosis | 0.91520604 |
91 | MP0004019_abnormal_vitamin_homeostasis | 0.91303295 |
92 | MP0004147_increased_porphyrin_level | 0.89487753 |
93 | MP0003172_abnormal_lysosome_physiology | 0.89169730 |
94 | MP0000703_abnormal_thymus_morphology | 0.88478222 |
95 | MP0001666_abnormal_nutrient_absorption | 0.88209908 |
96 | MP0005025_abnormal_response_to | 0.87615416 |
97 | MP0002420_abnormal_adaptive_immunity | 0.87399179 |
98 | MP0001819_abnormal_immune_cell | 0.87397945 |
99 | MP0001243_abnormal_dermal_layer | 0.86860518 |
100 | MP0005075_abnormal_melanosome_morpholog | 0.86359821 |
101 | MP0009672_abnormal_birth_weight | 0.86122821 |
102 | MP0002419_abnormal_innate_immunity | 0.85792271 |
103 | MP0002132_abnormal_respiratory_system | 0.84368569 |
104 | MP0010352_gastrointestinal_tract_polyps | 0.84368247 |
105 | MP0010030_abnormal_orbit_morphology | 0.84153267 |
106 | MP0001697_abnormal_embryo_size | 0.83844885 |
107 | MP0004087_abnormal_muscle_fiber | 0.83033060 |
108 | MP0006054_spinal_hemorrhage | 0.82520773 |
109 | MP0001835_abnormal_antigen_presentation | 0.82450408 |
110 | MP0001800_abnormal_humoral_immune | 0.82122182 |
111 | MP0002332_abnormal_exercise_endurance | 0.81374410 |
112 | MP0010155_abnormal_intestine_physiology | 0.80173183 |
113 | MP0001845_abnormal_inflammatory_respons | 0.79413602 |
114 | MP0000003_abnormal_adipose_tissue | 0.78917687 |
115 | MP0005670_abnormal_white_adipose | 0.78830605 |
116 | MP0003566_abnormal_cell_adhesion | 0.78768425 |
117 | MP0003786_premature_aging | 0.78696456 |
118 | MP0001849_ear_inflammation | 0.78558922 |
119 | MP0010307_abnormal_tumor_latency | 0.78384403 |
120 | MP0002136_abnormal_kidney_physiology | 0.77425722 |
121 | MP0001873_stomach_inflammation | 0.76882813 |
122 | MP0000716_abnormal_immune_system | 0.76859118 |
123 | MP0005000_abnormal_immune_tolerance | 0.76133562 |
124 | MP0005464_abnormal_platelet_physiology | 0.75942994 |
125 | MP0005266_abnormal_metabolism | 0.75566638 |
126 | MP0002970_abnormal_white_adipose | 0.74738997 |
127 | MP0002837_dystrophic_cardiac_calcinosis | 0.74281323 |
128 | MP0009053_abnormal_anal_canal | 0.73479598 |
129 | MP0004808_abnormal_hematopoietic_stem | 0.73207170 |
130 | MP0002106_abnormal_muscle_physiology | 0.72928232 |
131 | MP0000678_abnormal_parathyroid_gland | 0.72814505 |
132 | MP0001905_abnormal_dopamine_level | 0.72790593 |
133 | MP0003724_increased_susceptibility_to | 0.72685094 |
134 | MP0009642_abnormal_blood_homeostasis | 0.71958653 |
135 | MP0002723_abnormal_immune_serum | 0.71431127 |
136 | MP0000477_abnormal_intestine_morphology | 0.69738263 |
137 | MP0008058_abnormal_DNA_repair | 0.69672485 |
138 | MP0009763_increased_sensitivity_to | 0.68299160 |
139 | MP0005380_embryogenesis_phenotype | 0.67590200 |
140 | MP0001672_abnormal_embryogenesis/_devel | 0.67590200 |
141 | MP0008873_increased_physiological_sensi | 0.67562899 |
142 | MP0002877_abnormal_melanocyte_morpholog | 0.66601367 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.80114884 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.79592304 |
3 | Abnormal number of erythroid precursors (HP:0012131) | 3.67226654 |
4 | Reticulocytopenia (HP:0001896) | 3.66620558 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.60091539 |
6 | Vertebral compression fractures (HP:0002953) | 3.55017159 |
7 | Multiple enchondromatosis (HP:0005701) | 3.52227665 |
8 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.38139485 |
9 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.38139485 |
10 | Hepatic necrosis (HP:0002605) | 3.30274361 |
11 | Hepatocellular necrosis (HP:0001404) | 3.17027714 |
12 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.15777583 |
13 | Abnormality of glycolysis (HP:0004366) | 3.01078175 |
14 | Microvesicular hepatic steatosis (HP:0001414) | 2.99965651 |
15 | Macrocytic anemia (HP:0001972) | 2.93299758 |
16 | Rough bone trabeculation (HP:0100670) | 2.89864533 |
17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.88529722 |
18 | Deep venous thrombosis (HP:0002625) | 2.86342594 |
19 | Increased serum pyruvate (HP:0003542) | 2.85411882 |
20 | Hyperammonemia (HP:0001987) | 2.81663545 |
21 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.76983866 |
22 | Oral leukoplakia (HP:0002745) | 2.75292188 |
23 | Cholecystitis (HP:0001082) | 2.74781909 |
24 | Abnormal gallbladder physiology (HP:0012438) | 2.74781909 |
25 | Hypobetalipoproteinemia (HP:0003563) | 2.71744536 |
26 | Pallor (HP:0000980) | 2.70056777 |
27 | Nausea (HP:0002018) | 2.68631799 |
28 | Progressive muscle weakness (HP:0003323) | 2.68208315 |
29 | Hyperglycinuria (HP:0003108) | 2.67430278 |
30 | Myopathic facies (HP:0002058) | 2.64763893 |
31 | Abnormality of reticulocytes (HP:0004312) | 2.63151429 |
32 | Cerebral hypomyelination (HP:0006808) | 2.59296559 |
33 | Acute encephalopathy (HP:0006846) | 2.59162169 |
34 | Type I transferrin isoform profile (HP:0003642) | 2.59098071 |
35 | Late onset (HP:0003584) | 2.58001960 |
36 | Mitochondrial inheritance (HP:0001427) | 2.57676212 |
37 | Hepatosplenomegaly (HP:0001433) | 2.57606194 |
38 | Abnormal hemoglobin (HP:0011902) | 2.55859401 |
39 | Xanthomatosis (HP:0000991) | 2.51012921 |
40 | Cerebral edema (HP:0002181) | 2.49694630 |
41 | Angiofibromas (HP:0010615) | 2.49658987 |
42 | Adenoma sebaceum (HP:0009720) | 2.49658987 |
43 | Ragged-red muscle fibers (HP:0003200) | 2.49573542 |
44 | Trismus (HP:0000211) | 2.49043556 |
45 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.48324810 |
46 | Increased serum ferritin (HP:0003281) | 2.48132992 |
47 | Increased muscle lipid content (HP:0009058) | 2.47868391 |
48 | Ketosis (HP:0001946) | 2.47849820 |
49 | Distal lower limb muscle weakness (HP:0009053) | 2.46737486 |
50 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.45549788 |
51 | Increased serum lactate (HP:0002151) | 2.44937545 |
52 | Microretrognathia (HP:0000308) | 2.44490966 |
53 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.44457180 |
54 | Increased CSF lactate (HP:0002490) | 2.43436260 |
55 | Hypertensive crisis (HP:0100735) | 2.40363402 |
56 | Testicular atrophy (HP:0000029) | 2.39207003 |
57 | Hyperbilirubinemia (HP:0002904) | 2.38769249 |
58 | Reduced antithrombin III activity (HP:0001976) | 2.38011756 |
59 | Increased intramyocellular lipid droplets (HP:0012240) | 2.36172971 |
60 | Hypokinesia (HP:0002375) | 2.35552018 |
61 | Lactic acidosis (HP:0003128) | 2.32488686 |
62 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.30091070 |
63 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.29779963 |
64 | Progressive macrocephaly (HP:0004481) | 2.29461463 |
65 | Entropion (HP:0000621) | 2.27905811 |
66 | Intrahepatic cholestasis (HP:0001406) | 2.27671016 |
67 | Hyperglycinemia (HP:0002154) | 2.26627069 |
68 | Rhabdomyolysis (HP:0003201) | 2.26460171 |
69 | Muscle stiffness (HP:0003552) | 2.26364444 |
70 | Thrombocytosis (HP:0001894) | 2.26198273 |
71 | Acute necrotizing encephalopathy (HP:0006965) | 2.25349816 |
72 | Lethargy (HP:0001254) | 2.25248701 |
73 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.23459903 |
74 | Abnormality of glycine metabolism (HP:0010895) | 2.23459903 |
75 | Difficulty climbing stairs (HP:0003551) | 2.22849560 |
76 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.21285429 |
77 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.21285429 |
78 | Abnormality of glycolipid metabolism (HP:0010969) | 2.21285429 |
79 | Increased connective tissue (HP:0009025) | 2.20819648 |
80 | Nemaline bodies (HP:0003798) | 2.20586911 |
81 | Opisthotonus (HP:0002179) | 2.19629558 |
82 | Abnormality of nucleobase metabolism (HP:0010932) | 2.19225757 |
83 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.19002748 |
84 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.19002748 |
85 | Abnormal protein glycosylation (HP:0012346) | 2.19002748 |
86 | Abnormal glycosylation (HP:0012345) | 2.19002748 |
87 | Conjunctival hamartoma (HP:0100780) | 2.18770922 |
88 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.18091874 |
89 | Dicarboxylic aciduria (HP:0003215) | 2.18091874 |
90 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.17275737 |
91 | Respiratory failure (HP:0002878) | 2.15558748 |
92 | Renal Fanconi syndrome (HP:0001994) | 2.15501183 |
93 | Ketoacidosis (HP:0001993) | 2.13503186 |
94 | Delusions (HP:0000746) | 2.12581928 |
95 | Neonatal onset (HP:0003623) | 2.11990307 |
96 | Aplastic anemia (HP:0001915) | 2.11020616 |
97 | Cholelithiasis (HP:0001081) | 2.10547674 |
98 | Abnormality of the Achilles tendon (HP:0005109) | 2.10319140 |
99 | Abnormal cartilage morphology (HP:0002763) | 2.08349093 |
100 | Neoplasm of head and neck (HP:0012288) | 2.08133543 |
101 | Esophageal neoplasm (HP:0100751) | 2.08133543 |
102 | Distal lower limb amyotrophy (HP:0008944) | 2.07688444 |
103 | Broad distal phalanx of finger (HP:0009836) | 2.06516143 |
104 | Abnormal platelet function (HP:0011869) | 2.06427202 |
105 | Impaired platelet aggregation (HP:0003540) | 2.06427202 |
106 | Abnormal trabecular bone morphology (HP:0100671) | 2.06262067 |
107 | Spastic diplegia (HP:0001264) | 2.06244603 |
108 | Cerebral palsy (HP:0100021) | 2.06031473 |
109 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.05128362 |
110 | Reticulocytosis (HP:0001923) | 2.04950045 |
111 | Abnormality of iron homeostasis (HP:0011031) | 2.03703874 |
112 | Pancytopenia (HP:0001876) | 2.03163355 |
113 | CNS demyelination (HP:0007305) | 2.02720230 |
114 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.02652369 |
115 | Myoglobinuria (HP:0002913) | 2.02518886 |
116 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.02428490 |
117 | Hypoglycemic coma (HP:0001325) | 2.00195643 |
118 | Emotional lability (HP:0000712) | 1.99942335 |
119 | Verrucae (HP:0200043) | 1.99702532 |
120 | Papilloma (HP:0012740) | 1.99702532 |
121 | Gout (HP:0001997) | 1.99075090 |
122 | Petechiae (HP:0000967) | 1.98450351 |
123 | Microcytic anemia (HP:0001935) | 1.97844768 |
124 | Increased hepatocellular lipid droplets (HP:0006565) | 1.97621299 |
125 | Exercise intolerance (HP:0003546) | 1.97097810 |
126 | Fatigue (HP:0012378) | 1.95949005 |
127 | Generalized aminoaciduria (HP:0002909) | 1.95414855 |
128 | Hyperphosphaturia (HP:0003109) | 1.94511956 |
129 | Abnormality of lateral ventricle (HP:0030047) | 1.94054553 |
130 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.93594039 |
131 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.93251117 |
132 | Abnormality of the gallbladder (HP:0005264) | 1.92342989 |
133 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.91065389 |
134 | Abnormality of the anterior horn cell (HP:0006802) | 1.90655052 |
135 | Degeneration of anterior horn cells (HP:0002398) | 1.90655052 |
136 | Metabolic acidosis (HP:0001942) | 1.89451017 |
137 | Muscle fiber inclusion bodies (HP:0100299) | 1.87718569 |
138 | Exertional dyspnea (HP:0002875) | 1.87589893 |
139 | Fasciculations (HP:0002380) | 1.85789442 |
140 | Achilles tendon contracture (HP:0001771) | 1.85652264 |
141 | Secondary amenorrhea (HP:0000869) | 1.85135533 |
142 | Shoulder girdle muscle weakness (HP:0003547) | 1.83689483 |
143 | Abnormal gallbladder morphology (HP:0012437) | 1.82731952 |
144 | Multiple lipomas (HP:0001012) | 1.81901625 |
145 | Spastic paraparesis (HP:0002313) | 1.81679797 |
146 | Lipid accumulation in hepatocytes (HP:0006561) | 1.80894585 |
147 | Vomiting (HP:0002013) | 1.79869251 |
148 | Delayed CNS myelination (HP:0002188) | 1.79596442 |
149 | Orthostatic hypotension (HP:0001278) | 1.78973010 |
150 | Retinal dysplasia (HP:0007973) | 1.77288068 |
151 | Progressive microcephaly (HP:0000253) | 1.76500585 |
152 | Upper motor neuron abnormality (HP:0002127) | 1.74805886 |
153 | Dysautonomia (HP:0002459) | 1.74180304 |
Rank | Gene Set | Z-score |
---|---|---|
1 | VRK2 | 4.27292983 |
2 | PKN2 | 3.40459880 |
3 | NME2 | 3.28198705 |
4 | ERN1 | 3.20496096 |
5 | TRIB3 | 3.09955192 |
6 | MAP3K11 | 3.03060990 |
7 | TLK1 | 2.99202638 |
8 | EIF2AK1 | 2.98401235 |
9 | TESK2 | 2.92249965 |
10 | BCKDK | 2.84425309 |
11 | BUB1 | 2.82096322 |
12 | MAP3K10 | 2.32053233 |
13 | PIM2 | 2.25641058 |
14 | SMG1 | 2.20164567 |
15 | KDR | 2.12230721 |
16 | SCYL2 | 2.09025177 |
17 | TESK1 | 2.08914982 |
18 | MAP4K1 | 1.97928436 |
19 | LRRK2 | 1.75053715 |
20 | EEF2K | 1.64642273 |
21 | WEE1 | 1.64609683 |
22 | NEK1 | 1.60226756 |
23 | MAP2K3 | 1.58897341 |
24 | TAOK2 | 1.56712575 |
25 | TNK2 | 1.56612266 |
26 | PBK | 1.51466717 |
27 | BMX | 1.40715158 |
28 | SRPK1 | 1.39437937 |
29 | BLK | 1.34641684 |
30 | NEK9 | 1.34477305 |
31 | NEK2 | 1.33048414 |
32 | PRPF4B | 1.32509218 |
33 | MAP3K8 | 1.32094498 |
34 | FLT3 | 1.30734073 |
35 | RPS6KA4 | 1.29654445 |
36 | STK16 | 1.28277936 |
37 | GRK6 | 1.25635045 |
38 | LIMK1 | 1.23164529 |
39 | PAK4 | 1.18613595 |
40 | MAPKAPK3 | 1.17570031 |
41 | TBK1 | 1.13851420 |
42 | ZAP70 | 1.08529827 |
43 | CCNB1 | 1.08334935 |
44 | CDC7 | 1.07824034 |
45 | BRAF | 1.05543313 |
46 | DYRK3 | 1.05164446 |
47 | ILK | 0.98691191 |
48 | ABL2 | 0.98622686 |
49 | CDK19 | 0.96182734 |
50 | AURKA | 0.95564490 |
51 | EPHA2 | 0.94673451 |
52 | TAOK1 | 0.94415748 |
53 | NME1 | 0.90860417 |
54 | CDK7 | 0.90714860 |
55 | PDK2 | 0.87451120 |
56 | MAP3K12 | 0.85876121 |
57 | MAPK11 | 0.83900640 |
58 | TGFBR1 | 0.83632299 |
59 | MAP3K3 | 0.82817815 |
60 | CSNK1G3 | 0.82791090 |
61 | STK10 | 0.80516544 |
62 | DAPK3 | 0.79977740 |
63 | PRKG2 | 0.77227115 |
64 | PLK1 | 0.76865781 |
65 | DYRK1B | 0.74254447 |
66 | MAP2K2 | 0.73069661 |
67 | VRK1 | 0.72927974 |
68 | ARAF | 0.72807878 |
69 | PAK6 | 0.71771782 |
70 | CDK4 | 0.71673403 |
71 | RPS6KB2 | 0.71621748 |
72 | PRKD3 | 0.70100811 |
73 | BTK | 0.69347106 |
74 | CLK1 | 0.68232025 |
75 | LMTK2 | 0.67628830 |
76 | EIF2AK3 | 0.66459734 |
77 | AKT2 | 0.64806373 |
78 | PIM1 | 0.64624833 |
79 | MOS | 0.64266858 |
80 | TYK2 | 0.61999532 |
81 | ICK | 0.61905496 |
82 | CHEK2 | 0.60896590 |
83 | ATR | 0.60432288 |
84 | CDK14 | 0.60272709 |
85 | AURKB | 0.60196503 |
86 | TTN | 0.59245502 |
87 | CDK11A | 0.59094693 |
88 | SIK3 | 0.58835644 |
89 | RAF1 | 0.57164398 |
90 | PAK1 | 0.56669845 |
91 | PTK6 | 0.55778514 |
92 | DAPK1 | 0.54218124 |
93 | CDK15 | 0.52150076 |
94 | NTRK1 | 0.51978894 |
95 | BRSK1 | 0.51540565 |
96 | PIK3CG | 0.50965313 |
97 | FGFR4 | 0.50846470 |
98 | CSNK1A1L | 0.50490845 |
99 | SIK1 | 0.49720832 |
100 | CDK18 | 0.49617287 |
101 | KIT | 0.48735263 |
102 | CDK8 | 0.46468496 |
103 | ACVR1B | 0.45786100 |
104 | PRKCI | 0.45091220 |
105 | ALK | 0.44650742 |
106 | CSNK2A1 | 0.42914920 |
107 | RPS6KA5 | 0.40781178 |
108 | TSSK6 | 0.39655069 |
109 | GRK5 | 0.39625500 |
110 | MAP2K6 | 0.39581017 |
111 | ZAK | 0.38212985 |
112 | IKBKE | 0.37797995 |
113 | SYK | 0.36997851 |
114 | FES | 0.36757087 |
115 | MATK | 0.36610075 |
116 | JAK2 | 0.36431993 |
117 | IRAK3 | 0.36384447 |
118 | TTK | 0.36036768 |
119 | CDK9 | 0.35898159 |
120 | MAP3K1 | 0.35856996 |
121 | BRSK2 | 0.35170020 |
122 | PLK3 | 0.34997017 |
123 | CHEK1 | 0.34400044 |
124 | CSNK2A2 | 0.33359104 |
125 | MAPKAPK2 | 0.32879817 |
126 | MARK3 | 0.32591427 |
127 | MAP2K7 | 0.32298040 |
128 | CAMK2G | 0.31506917 |
129 | MAPK4 | 0.29925543 |
130 | MYLK | 0.29718865 |
131 | PHKG1 | 0.28227770 |
132 | PHKG2 | 0.28227770 |
133 | CSNK1G2 | 0.28000072 |
134 | PASK | 0.26865978 |
135 | RPS6KA1 | 0.26837399 |
136 | STK4 | 0.26543252 |
137 | MAPK15 | 0.25928041 |
138 | RPS6KC1 | 0.25726909 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 4.19321942 |
2 | DNA replication_Homo sapiens_hsa03030 | 3.46000070 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.75321282 |
4 | Proteasome_Homo sapiens_hsa03050 | 2.74108508 |
5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.42920557 |
6 | Mismatch repair_Homo sapiens_hsa03430 | 2.38727100 |
7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.26693096 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.26195705 |
9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.25315242 |
10 | Sulfur relay system_Homo sapiens_hsa04122 | 2.20245267 |
11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.06665923 |
12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.04377949 |
13 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.02506628 |
14 | Base excision repair_Homo sapiens_hsa03410 | 1.99371737 |
15 | Carbon metabolism_Homo sapiens_hsa01200 | 1.95362146 |
16 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.95102509 |
17 | Spliceosome_Homo sapiens_hsa03040 | 1.92401390 |
18 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.88644651 |
19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.85731453 |
20 | RNA polymerase_Homo sapiens_hsa03020 | 1.84544737 |
21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.74139447 |
22 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.61335062 |
23 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58448897 |
24 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.57710620 |
25 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.56347636 |
26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.56152187 |
27 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.55553247 |
28 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.54030069 |
29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.53805040 |
30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.53231417 |
31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.43564376 |
32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.42977235 |
33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.42778910 |
34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.38199067 |
35 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37671328 |
36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37127840 |
37 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.34106797 |
38 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.32482160 |
39 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.28767597 |
40 | Huntingtons disease_Homo sapiens_hsa05016 | 1.21994310 |
41 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.20204246 |
42 | RNA transport_Homo sapiens_hsa03013 | 1.20139317 |
43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.17344644 |
44 | Homologous recombination_Homo sapiens_hsa03440 | 1.16591431 |
45 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.10613785 |
46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.09727363 |
47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.09400177 |
48 | Peroxisome_Homo sapiens_hsa04146 | 1.04664552 |
49 | Galactose metabolism_Homo sapiens_hsa00052 | 1.02692932 |
50 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.97673736 |
51 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.96906392 |
52 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.93125603 |
53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88453801 |
54 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.83130458 |
55 | Alzheimers disease_Homo sapiens_hsa05010 | 0.82275832 |
56 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.82144382 |
57 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79653282 |
58 | Bladder cancer_Homo sapiens_hsa05219 | 0.78820670 |
59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.78703561 |
60 | Cell cycle_Homo sapiens_hsa04110 | 0.77679708 |
61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77515205 |
62 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.76335426 |
63 | Thyroid cancer_Homo sapiens_hsa05216 | 0.75780002 |
64 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.75361582 |
65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75241230 |
66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75192533 |
67 | Lysosome_Homo sapiens_hsa04142 | 0.72988486 |
68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71391832 |
69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70588354 |
70 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.69704890 |
71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.69605637 |
72 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.68648394 |
73 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.66511655 |
74 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.66274833 |
75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66090617 |
76 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65584390 |
77 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65509771 |
78 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64086925 |
79 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.62718475 |
80 | Purine metabolism_Homo sapiens_hsa00230 | 0.62486450 |
81 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.59319229 |
82 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.57297001 |
83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.55356092 |
84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52888215 |
85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.52356312 |
86 | Protein export_Homo sapiens_hsa03060 | 0.52184759 |
87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52027406 |
88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51827396 |
89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.51562419 |
90 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51165166 |
91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.49876259 |
92 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49670965 |
93 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.49497675 |
94 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49036649 |
95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.47368004 |
96 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46273448 |
97 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45174189 |
98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.44687984 |
99 | Lysine degradation_Homo sapiens_hsa00310 | 0.44543020 |
100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44451328 |
101 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44447354 |
102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.42847871 |
103 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42334052 |
104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41519828 |
105 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41483964 |
106 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.41190060 |
107 | Shigellosis_Homo sapiens_hsa05131 | 0.39866678 |
108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39092408 |
109 | Salmonella infection_Homo sapiens_hsa05132 | 0.38528172 |
110 | Endocytosis_Homo sapiens_hsa04144 | 0.38222763 |
111 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37679874 |
112 | Apoptosis_Homo sapiens_hsa04210 | 0.34937697 |
113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.34525476 |
114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.34409467 |
115 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.33733776 |
116 | Legionellosis_Homo sapiens_hsa05134 | 0.33138526 |
117 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.32813651 |
118 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31800442 |
119 | RNA degradation_Homo sapiens_hsa03018 | 0.29189448 |
120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28944880 |
121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.27900178 |
122 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.27720858 |
123 | Viral myocarditis_Homo sapiens_hsa05416 | 0.26985670 |
124 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.25708270 |
125 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.25061200 |
126 | Bile secretion_Homo sapiens_hsa04976 | 0.23237754 |
127 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.22551665 |
128 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.21977006 |
129 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.16203609 |